CA-GENERATE-CAPITAL
31.1.2024 16:01:35 CET | Business Wire | Press release
Today, Generate Capital (“Generate”), a leading sustainable infrastructure platform, announced the closing of its latest capital raise with $1.5 billion in new capital commitments from preeminent global institutional investors. The California State Teachers’ Retirement System (“CalSTRS”), the world’s largest educator-only pension fund, joined other new investors such as HESTA, as well as existing investors including QIC and AustralianSuper, in the financing. This new round brings the total capital raised by Generate since its inception in 2014 to over $10 billion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240130298422/en/
In partnership with project developers, technology companies, and investors, Generate has established a diverse portfolio of thousands of sustainable infrastructure projects around the world. (Photo: Business Wire)
Over the last decade, Generate has developed a creative and flexible platform dedicated entirely to accelerating the infrastructure transition – from building and financing infrastructure assets to incubating, building and financing leading infrastructure companies. The result is an integrated offering – a “one-stop shop” – for capital, innovators, customers, and communities committed to rebuilding the world. Since its founding, Generate has partnered with more than 50 project development and technology companies, dozens of investors and hundreds of communities to establish a diverse portfolio of thousands of sustainable infrastructure projects around the world.
As of September 2023, Generate helped produce over 320GWh of sustainable power and process more than 715Kt in organic waste. In addition to its project portfolio, Generate’s subsidiaries and portfolio companies are leading the infrastructure transition, bringing value to waste through Generate Upcycle, making the electric grid more reliable through esVolta, and expanding renewable power generation with Nexamp and Pine Gate Renewables. In 2023, Generate expanded its creative approach to accelerating the transition by entering joint ventures with Blue Bird Corporation to bring electric school buses to districts across the country and with McKinstry to accelerate energy efficiency with municipal customers. The flexibility and innovation of the platform combined with its record of success providing compelling returns to investors allowed for a successful fundraise in a more constrained capital markets environment.
“We're at an inflection point in the transition to a clean energy economy,” says Generate Capital CEO and co-founder Scott Jacobs. “While the window for action is getting smaller every day, we have the blueprints to build the critical infrastructure that will ensure a livable future. We need to invest trillions, not billions. Ten billion dollars is just a start. We are incredibly proud that our differentiated model integrating finance and operations, meshing innovation with scale, harnessing top talent, and being totally dedicated to this transition attracts the world’s best partners and continues to deliver for our investors and communities.”
CalSTRS' participation in this capital raise establishes a strategic partnership with Generate and deepens their ongoing investment in the platform.
“Our mission is to provide a secure retirement for California’s public educators and beneficiaries,” said Kirsty Jenkinson, CalSTRS' Director of Sustainable Investment and Stewardship Strategies. “Our strategic partnership with Generate Capital aligns with our mission to deliver superior financial returns for our portfolio while creating demonstrable positive outcomes for the environment and society.”
“Generate Capital has delivered strong returns for AustralianSuper members,” said AustralianSuper Global Head of Real Assets, Nik Kemp. “We look forward to Generate continuing to deliver great performance while also playing a pivotal role in the global clean infrastructure transition.”
Some of Generate’s key 2023 highlights include:
- Over $2 billion invested in the energy transition, building more infrastructure assets, growing infrastructure companies, and financing leading players.
- Viridis Initiative, a joint venture established with McKinstry, was launched to deliver turnkey energy-as-a-service (EaaS) solutions to municipalities, universities, schools, and hospitals.
- Clean Bus Solutions, a joint venture established with the Blue Bird Corporation, was launched to meet the increasing demand for electric school buses and accelerate the adoption of clean transportation of students in North America.
- Generate helped Hillsborough County Public Schools finance, install and maintain energy efficiency solutions across its facilities. This resulted in the district avoiding $13 million in annual utility costs, reduction in CO2 emissions by 45,000 metric tons, and improved air quality in 100% of the public schools as of July 2023.
- Pine Gate Renewables, in which Generate has partnered with the founding team to invest and build the company, became the country’s third-largest solar developer.
- esVolta, a Generate subsidiary, closed one of the energy storage industry’s first standalone storage tax equity investments, taking advantage of the Inflation Reduction Act with U.S. Bank to finance the completion of a 30MW/60MWh utility-scale energy storage project in California.
- Ubiquity, in which Generate has partnered with the founding team to invest and build the company, is now both the largest and fastest growing open-access broadband network in the country.
About Generate Capital
Generate Capital, PBC is a leading sustainable investment and operating company driving the infrastructure transition. Generate builds, owns, operates and finances clean energy, transportation, water, waste, agriculture and digital infrastructure. Founded in 2014, Generate has partnered with over 50 technology and project developers and owns and operates more than 2,000 assets globally. Generate is a one-stop-shop offering pioneers of the infrastructure revolution tailored funding and support needed to get projects built. The company’s Infrastructure-as-a-Service model delivers affordable, reliable and sustainable resources to thousands of customers, companies, communities, school districts and universities. Together, we are rebuilding the world. For more information, please visit www.generatecapital.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240130298422/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
